DOCSLIB.ORG

Table S1. Genes Significantly Altered in the Thyroid Glands of Rcchan Wistar Rats After a Sub-Chronically Exposed to AA (3 Mg/Kg Bw/Day) in Drinking Water

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Table S1. Genes Significantly Altered in the Thyroid Glands of Rcchan Wistar Rats After a Sub-Chronically Exposed to AA (3 Mg/Kg Bw/Day) in Drinking Water Table S1. Genes significantly altered in the thyroid glands of RccHan Wistar rats after a sub-chronically exposed to AA (3 mg/Kg bw/day) in drinking water. Fold Fold Fold Entrez Change Change Change Probe Name Gen bank Accession GeneID Gene Symbol Gene Name p-value MN MN p-value FN FN p-value FM FM A_64_P120327 XM_001078857 29605 Myh13 myosin, heavy chain 13, skeletal muscle 4.99E-02 -12.5 2.85E-01 NS 9.39E-02 NS A_44_P124219 NM_001013247 367086 Sln sarcolipin 3.51E-03 -6.8 2.48E-01 NS 7.88E-02 NS A_44_P435713 NM_001010970 24203 Amy1a amylase, alpha 1A (salivary) 2.13E-02 -6.7 3.06E-01 NS 5.04E-02 NS heat shock protein family, member 7 A_43_P15812 NM_031607 50565 Hspb7 (cardiovascular) 3.56E-02 -6.4 2.37E-02 -2.6 6.54E-02 NS A_64_P116108 XR_008539 4.43E-02 -5.9 2.54E-01 NS 4.31E-02 2.4 A_44_P116652 NM_019298 54240 Chrnd cholinergic receptor, nicotinic, delta 4.28E-02 -5.8 2.22E-01 NS 1.39E-02 2.5 A_42_P600215 NM_175844 286965 Abra actin-binding Rho activating protein 2.44E-02 -5.8 1.35E-01 NS 1.92E-01 NS A_44_P142837 XM_236702 316071 Xirp1 xin actin-binding repeat containing 1 3.79E-02 -5.8 1.62E-01 NS 2.08E-01 NS similar to Myosin light polypeptide 4 A_42_P643349 NM_001109495 688228 LOC688228 (Myosin light chain 1, atrial isoform) 3.98E-02 -5.6 1.52E-01 NS 1.35E-01 NS A_64_P107409 XM_001071732 498267 Dusp27 dual specificity phosphatase 27 (putative) 4.78E-02 -5.5 1.36E-01 NS 5.32E-02 NS A_64_P029501 NM_001034105 290561 Tnnc1 troponin C type 1 (slow) 4.95E-02 -5.5 1.69E-01 NS 2.93E-01 NS A_44_P217919 NM_001106148 291605 Myot myotilin 4.88E-02 -5.0 1.13E-01 NS 8.19E-02 NS A_64_P022654 NM_001109085 498316 LOC498316 hypothetical LOC498316 1.30E-02 -4.9 1.34E-01 NS 6.69E-02 NS SH3 domain binding glutamic acid-rich A_44_P471450 NM_001127682 498066 Sh3bgr protein 4.29E-02 -4.8 1.62E-01 NS 5.02E-02 NS A_44_P532133 XR_008863 1.80E-02 -4.8 2.44E-01 NS 1.02E-01 NS A_64_P102049 NM_001109401 680319 LOC680319 hypothetical protein LOC680319 3.67E-02 -4.7 1.17E-01 NS 2.69E-01 NS A_64_P042586 NM_001013039 259167 Art5 ADP-ribosyltransferase 5 1.47E-02 -4.6 6.83E-02 NS 8.88E-02 NS ubiquitin-conjugating enzyme E2Q family- A_64_P042302 NM_001145163 679949 Ube2ql1 like 1 2.05E-02 -4.6 9.87E-02 NS 1.64E-01 NS A_44_P352331 NM_001077590 365603 Bves blood vessel epicardial substance 2.85E-02 -4.5 9.05E-02 NS 6.22E-02 NS A_64_P130627 NM_001013930 298139 LOC298139 similar to RIKEN cDNA 2310003M01 4.52E-02 -4.5 2.48E-01 NS 5.16E-02 NS fibronectin type III and SPRY domain A_44_P503708 XM_001062337 308779 Fsd2 containing 2 4.42E-02 -4.4 9.03E-02 NS 4.75E-02 4.5 A_64_P102043 NM_001109401 680319 LOC680319 hypothetical protein LOC680319 4.62E-02 -4.4 8.25E-02 NS 4.34E-01 NS A_64_P060094 NM_001012001 301033 Lrrc2 leucine rich repeat containing 2 3.57E-02 -4.4 9.66E-02 NS 1.20E-01 NS A_44_P389448 XM_228900 317454 RGD1560334 similar to Myosin light chain 1 slow a 4.12E-02 -4.3 4.94E-01 NS 3.87E-01 NS A_64_P026858 NM_001106451 295315 Tbx15 T-box 15 4.39E-02 -4.3 1.39E-01 NS 2.99E-02 3.3 A_64_P100059 XM_213443 287659 Socs7 suppressor of cytokine signaling 7 4.44E-02 -4.2 1.47E-01 NS 2.80E-02 3.4 A_64_P165386 NM_001109333 502225 Lrrc14b leucine rich repeat containing 14B 3.61E-02 -4.2 1.02E-01 NS 2.25E-03 8.1 triggering receptor expressed on myeloid A_44_P354415 NM_001106885 301229 Trem1 cells 1 1.26E-04 -4.2 9.60E-01 NS 1.62E-01 NS A_64_P162476 NM_001107541 308873 Art1 ADP-ribosyltransferase 1 3.62E-02 -4.1 1.13E-01 NS 1.26E-01 NS potassium voltage-gated channel, Isk- A_64_P034740 NM_001101003 681190 Kcne1l related family, member 1-like 1.92E-02 -4.0 5.12E-01 NS 9.90E-03 4.7 acyl-Coenzyme A oxidase 2, branched A_44_P330188 NM_145770 252898 Acox2 chain 5.71E-03 -3.9 2.23E-03 -2.1 7.64E-02 NS A_44_P478313 XR_008378 4.72E-03 -3.9 2.44E-02 -1.6 6.03E-01 NS A_43_P12768 NM_053328 79431 Bhlhe40 basic helix-loop-helix family, member e40 9.78E-04 -3.9 1.78E-01 NS 1.73E-01 NS A_44_P1035007 NM_017194 29422 Chrne cholinergic receptor, nicotinic, epsilon 1.32E-02 -3.8 3.34E-01 NS 6.00E-03 4.0 ankyrin repeat and SOCS box-containing A_64_P099897 NM_001170749 680076 Asb14 14 3.63E-02 -3.7 8.52E-02 NS 3.86E-02 4.8 A_44_P384090 NM_022531 64362 Des desmin 4.91E-02 -3.6 6.76E-02 NS 9.33E-02 NS A_64_P311745 NM_001107987 313625 Myom3 myomesin family, member 3 1.52E-02 -3.6 1.09E-01 NS 1.72E-01 NS ATPase, (Na+)/K+ transporting, beta 4 A_43_P12790 NM_053381 84396 Atp1b4 polypeptide 3.51E-02 -3.6 1.08E-01 NS 1.40E-01 NS A_44_P390995 NM_013044 25566 Tmod1 tropomodulin 1 2.12E-02 -3.6 1.29E-01 NS 3.61E-02 3.6 C1q and tumor necrosis factor related A_44_P835847 NM_001134436 294806 C1qtnf3 protein 3 4.16E-03 -3.6 4.52E-02 -2.9 7.08E-02 NS A_64_P237784 XM_001073426 690139 Rbm24 RNA binding motif protein 24 1.11E-02 -3.5 2.03E-01 NS 4.51E-02 3.0 A_64_P082540 NM_145877 113886 Kif1c kinesin family member 1C 4.43E-02 -3.5 3.69E-02 -2.2 5.63E-01 NS A_44_P139291 NM_001135778 680409 Prodh proline dehydrogenase 3.76E-02 -3.5 1.28E-03 1.9 9.64E-01 NS A_44_P548611 XM_001054443 317224 Fndc3c1 fibronectin type III domain containing 3C1 1.62E-02 -3.5 8.68E-02 NS 9.89E-02 NS A_64_P137486 XM_001068161 688750 Cd209g CD209g molecule 8.19E-04 -3.5 3.06E-02 -2.0 1.04E-01 NS ankyrin repeat and SOCS box-containing A_64_P127488 XM_001055574 680076 Asb14 14 2.35E-02 -3.5 3.96E-02 -3.5 6.20E-02 NS A_43_P15638 NM_053861 116640 Tnc tenascin C 6.60E-03 -3.4 7.88E-01 NS 2.71E-02 5.1 A_44_P210852 NM_001034187 307472 Sh3rf2 SH3 domain containing ring finger 2 4.62E-02 -3.4 6.07E-02 NS 3.43E-02 2.6 A_43_P19787 XM_001054550 4.92E-02 -3.4 9.51E-01 NS 6.25E-01 NS A_42_P464434 XM_215498 7.25E-03 -3.4 4.75E-02 -3.9 2.09E-01 NS leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), A_64_P111058 NM_001037357 361493 Lilrb3l member 3-like 1.27E-02 -3.4 5.87E-02 NS 2.68E-01 NS cytochrome P450, family 2, subfamily e, A_44_P409232 NM_031543 25086 Cyp2e1 polypeptide 1 1.59E-03 -3.4 2.79E-01 NS 1.80E-02 2.4 glutamine-fructose-6-phosphate A_43_P18793 NM_001002819 360518 Gfpt2 transaminase 2 2.14E-02 -3.4 1.99E-02 -1.8 4.66E-02 2.2 A_42_P540920 NM_001135045 363153 Arpp-21 cyclic AMP-regulated phosphoprotein 4.51E-02 -3.4 1.51E-01 NS 3.74E-02 3.1 A_64_P074440 XM_001073426 690139 Rbm24 RNA binding motif protein 24 6.62E-03 -3.3 1.10E-01 NS 7.11E-02 NS A_64_P078862 NM_019183 29275 Actc1 actin, alpha, cardiac muscle 1 9.43E-03 -3.3 1.72E-01 NS 4.06E-02 3.3 A_44_P638191 XM_574086 498803 Otud1 OTU domain containing 1 1.48E-02 -3.3 3.21E-01 NS 2.02E-01 NS A_44_P135650 XM_001069604 311167 Smtnl1 smoothelin-like 1 3.77E-02 -3.3 1.49E-01 NS 7.14E-02 NS A_64_P161818 NM_001107985 313610 Extl1 exostoses (multiple)-like 1 4.03E-02 -3.3 1.59E-01 NS 3.37E-02 2.7 A_64_P023355 XM_001081149 4.71E-02 -3.3 1.58E-01 NS 2.32E-02 -2.4 A_64_P053785 NM_012739 25083 Adra2a adrenergic, alpha-2A-, receptor 6.63E-03 -3.3 2.33E-01 NS 1.98E-01 NS potassium voltage-gated channel, shaker- A_64_P000870 NM_001108914 365241 Kcna7 related subfamily, member 7 2.04E-02 -3.3 2.39E-02 -2.1 3.70E-01 NS A_64_P005581 NM_001038615 308099 Fndc1 fibronectin type III domain containing 1 1.85E-02 -3.3 4.97E-02 -1.6 3.58E-02 3.2 similar to Tumor necrosis factor, alpha- induced protein 3 (Putative DNA binding A_64_P101950 XM_001060914 683206 LOC683206 protein A20) (Zinc finger protein A20) 4.37E-02 -3.2 6.02E-01 NS 4.91E-01 NS A_64_P127789 XM_002729912 691933 LOC691933 similar to Protein C6orf142 homolog 4.00E-02 -3.2 8.47E-02 NS 1.08E-01 NS A_64_P095586 NM_001109085 498316 LOC498316 hypothetical LOC498316 6.93E-03 -3.2 1.19E-01 NS 1.05E-01 NS creatine kinase, mitochondrial 2, A_42_P615837 NM_001127652 688698 Ckmt2 sarcomeric 4.90E-02 -3.1 1.35E-01 NS 1.54E-01 NS A_44_P367761 NM_012923 25405 Ccng1 cyclin G1 2.10E-02 -3.1 3.78E-02 -3.9 1.48E-01 NS glutamic-oxaloacetic transaminase 1, A_44_P388973 NM_012571 24401 Got1 soluble (aspartate aminotransferase 1) 2.52E-02 -3.1 3.66E-01 NS 6.62E-02 NS A_44_P134143 NM_053612 113906 Hspb8 heat shock protein B8 4.12E-02 -3.1 1.53E-01 NS 4.11E-02 3.3 CAP, adenylate cyclase-associated protein, A_43_P12967 NM_053874 116653 Cap2 2 (yeast) 4.59E-02 -3.1 5.52E-02 NS 6.78E-02 NS similar to T-box transcription factor TBX15 A_64_P023715 XM_575564 500213 LOC500213 (T-box protein 15) (MmTBx8) 6.36E-04 -3.1 2.51E-01 NS 3.50E-01 NS ankyrin repeat and SOCS box-containing A_44_P621454 NM_001109216 499972 Asb10 10 3.41E-02 -3.1 4.19E-02 -2.1 8.64E-02 NS A_42_P476474 NM_001033926 25177 Fhl1 four and a half LIM domains 1 4.16E-02 -3.1 1.49E-01 NS 1.18E-01 NS A_64_P099452 NM_030828 58920 Gpc1 glypican 1 1.26E-02 -3.0 9.17E-02 NS 1.21E-01 NS A_64_P043161 NM_001127547 315191 Fbln1 fibulin 1 2.12E-02 -3.0 1.09E-01 NS 1.29E-01 NS ribonuclease, RNase A family, 2 (liver, A_42_P782235 NM_001007015 474169 Rnase2 eosinophil-derived neurotoxin) 1.97E-02 -3.0 1.97E-01 NS 6.02E-01 NS A_64_P100983 NM_001025008 314996 Klhl38 kelch-like 38 (Drosophila) 3.16E-02 -3.0 9.44E-02 NS 7.45E-02 NS A_64_P140275 NM_001107765 311348 Cdan1 congenital dyserythropoietic anemia, type I 4.82E-02 -3.0 5.64E-01 NS 6.89E-01 NS A_44_P112551 NM_001108180 315962 Ky kyphoscoliosis peptidase 1.91E-02 -3.0 3.14E-02 -2.5 4.14E-02 2.8 A_42_P765066 NM_021588 59108 Mb myoglobin 3.88E-02 -3.0 1.34E-01 NS 2.54E-01 NS wingless-type MMTV integration site family, A_64_P092782 NM_001109223 500047 Wnt16 member 16 1.34E-02 -3.0 1.70E-01 NS 7.50E-02 NS V-set domain containing T cell activation A_64_P078624 NM_001024244 295322 Vtcn1 inhibitor 1 1.89E-02 -2.9 1.29E-01 NS 4.06E-01 NS A_44_P478176 NM_001109637 691307 Lrrc39 leucine rich repeat containing 39 3.47E-02 -2.9 1.60E-01 NS 1.56E-01 NS
Load more

Recommended publications
  • Table S1 the Four Gene Sets Derived from Gene Expression Profiles of Escs and Differentiated Cells
    Table S1 The four gene sets derived from gene expression profiles of ESCs and differentiated cells Uniform High Uniform Low ES Up ES Down EntrezID GeneSymbol EntrezID GeneSymbol EntrezID GeneSymbol EntrezID GeneSymbol 269261 Rpl12 11354 Abpa 68239 Krt42 15132 Hbb-bh1 67891 Rpl4 11537 Cfd 26380 Esrrb 15126 Hba-x 55949 Eef1b2 11698 Ambn 73703 Dppa2 15111 Hand2 18148 Npm1 11730 Ang3 67374 Jam2 65255 Asb4 67427 Rps20 11731 Ang2 22702 Zfp42 17292 Mesp1 15481 Hspa8 11807 Apoa2 58865 Tdh 19737 Rgs5 100041686 LOC100041686 11814 Apoc3 26388 Ifi202b 225518 Prdm6 11983 Atpif1 11945 Atp4b 11614 Nr0b1 20378 Frzb 19241 Tmsb4x 12007 Azgp1 76815 Calcoco2 12767 Cxcr4 20116 Rps8 12044 Bcl2a1a 219132 D14Ertd668e 103889 Hoxb2 20103 Rps5 12047 Bcl2a1d 381411 Gm1967 17701 Msx1 14694 Gnb2l1 12049 Bcl2l10 20899 Stra8 23796 Aplnr 19941 Rpl26 12096 Bglap1 78625 1700061G19Rik 12627 Cfc1 12070 Ngfrap1 12097 Bglap2 21816 Tgm1 12622 Cer1 19989 Rpl7 12267 C3ar1 67405 Nts 21385 Tbx2 19896 Rpl10a 12279 C9 435337 EG435337 56720 Tdo2 20044 Rps14 12391 Cav3 545913 Zscan4d 16869 Lhx1 19175 Psmb6 12409 Cbr2 244448 Triml1 22253 Unc5c 22627 Ywhae 12477 Ctla4 69134 2200001I15Rik 14174 Fgf3 19951 Rpl32 12523 Cd84 66065 Hsd17b14 16542 Kdr 66152 1110020P15Rik 12524 Cd86 81879 Tcfcp2l1 15122 Hba-a1 66489 Rpl35 12640 Cga 17907 Mylpf 15414 Hoxb6 15519 Hsp90aa1 12642 Ch25h 26424 Nr5a2 210530 Leprel1 66483 Rpl36al 12655 Chi3l3 83560 Tex14 12338 Capn6 27370 Rps26 12796 Camp 17450 Morc1 20671 Sox17 66576 Uqcrh 12869 Cox8b 79455 Pdcl2 20613 Snai1 22154 Tubb5 12959 Cryba4 231821 Centa1 17897
    [Show full text]
  • Table 2. Significant
    Table 2. Significant (Q < 0.05 and |d | > 0.5) transcripts from the meta-analysis Gene Chr Mb Gene Name Affy ProbeSet cDNA_IDs d HAP/LAP d HAP/LAP d d IS Average d Ztest P values Q-value Symbol ID (study #5) 1 2 STS B2m 2 122 beta-2 microglobulin 1452428_a_at AI848245 1.75334941 4 3.2 4 3.2316485 1.07398E-09 5.69E-08 Man2b1 8 84.4 mannosidase 2, alpha B1 1416340_a_at H4049B01 3.75722111 3.87309653 2.1 1.6 2.84852656 5.32443E-07 1.58E-05 1110032A03Rik 9 50.9 RIKEN cDNA 1110032A03 gene 1417211_a_at H4035E05 4 1.66015788 4 1.7 2.82772795 2.94266E-05 0.000527 NA 9 48.5 --- 1456111_at 3.43701477 1.85785922 4 2 2.8237185 9.97969E-08 3.48E-06 Scn4b 9 45.3 Sodium channel, type IV, beta 1434008_at AI844796 3.79536664 1.63774235 3.3 2.3 2.75319499 1.48057E-08 6.21E-07 polypeptide Gadd45gip1 8 84.1 RIKEN cDNA 2310040G17 gene 1417619_at 4 3.38875643 1.4 2 2.69163229 8.84279E-06 0.0001904 BC056474 15 12.1 Mus musculus cDNA clone 1424117_at H3030A06 3.95752801 2.42838452 1.9 2.2 2.62132809 1.3344E-08 5.66E-07 MGC:67360 IMAGE:6823629, complete cds NA 4 153 guanine nucleotide binding protein, 1454696_at -3.46081884 -4 -1.3 -1.6 -2.6026947 8.58458E-05 0.0012617 beta 1 Gnb1 4 153 guanine nucleotide binding protein, 1417432_a_at H3094D02 -3.13334396 -4 -1.6 -1.7 -2.5946297 1.04542E-05 0.0002202 beta 1 Gadd45gip1 8 84.1 RAD23a homolog (S.
    [Show full text]
  • Molecular Dynamics and Evolutionary Aspects of the Transition from the Fully Grown Oocyte to Embryo
    Downloaded from genesdev.cshlp.org on September 26, 2021 - Published by Cold Spring Harbor Laboratory Press Cracking the egg: molecular dynamics and evolutionary aspects of the transition from the fully grown oocyte to embryo Alexei V. Evsikov,1,5 Joel H. Graber,1 J. Michael Brockman,1,2 Aleš Hampl,3 Andrea E. Holbrook,1 Priyam Singh,1,2 John J. Eppig,1 Davor Solter,1,4 and Barbara B. Knowles1 1The Jackson Laboratory, Bar Harbor, Maine 04609, USA; 2 Bioinformatics Program, Boston University, Boston, Massachusetts 02215, USA; 3Masaryk University Brno and Institute of Experimental Medicine, 625 00 Brno, Czech Republic; 4Max Planck Institute of Immunobiology, 79108 Freiburg, Germany Fully grown oocytes (FGOs) contain all the necessary transcripts to activate molecular pathways underlying the oocyte-to-embryo transition (OET). To elucidate this critical period of development, an extensive survey of the FGO transcriptome was performed by analyzing 19,000 expressed sequence tags of the Mus musculus FGO cDNA library. Expression of 5400 genes and transposable elements is reported. For a majority of genes expressed in mouse FGOs, homologs transcribed in eggs of Xenopus laevis or Ciona intestinalis were found, pinpointing evolutionary conservation of most regulatory cascades underlying the OET in chordates. A large proportion of identified genes belongs to several gene families with oocyte-restricted expression, a likely result of lineage-specific genomic duplications. Gene loss by mutation and expression in female germline of retrotransposed genes specific to M. musculus is documented. These findings indicate rapid diversification of genes involved in female reproduction. Comparison of the FGO and two-cell embryo transcriptomes demarcated the processes important for oogenesis from those involved in OET and identified novel motifs in maternal mRNAs associated with transcript stability.
    [Show full text]
  • Suppl 1.1 All Data Dimethyl Labled
    Fasta headers Protein names Gene names Uniprot Ratio H/L normalized exp01 Ratio H/L normalized exp02 Ratio H/L normalized exp03 Ratio H/L normalized exp04 Ratio H/L normalized exp05 Ratio H/L normalized exp06 Ratio H/L normalized exp07 Ratio H/L normalized exp08 Ratio H/L normalized exp09 Ratio H/L normalized exp10 Ratio H/L normalized exp11b Ratio H/L normalized exp12b Peptides exp01 Peptides exp02 Peptides exp03 Peptides exp04 Peptides exp05 Peptides exp06 Peptides exp07 Peptides exp08 Peptides exp09 Peptides exp10 Peptides exp11b Peptides exp12b Unique peptides exp01 Unique peptides exp02 Unique peptides exp03 Unique peptides exp04 Unique peptides exp05 Unique peptides exp06 Unique peptides exp07 Unique peptides exp08 >sp|P01876|IGHA1_HUMAN Ig alpha-1 chain C region OS=Homo sapiens GN=IGHA1 PE=1 SV=2Ig alpha-1 chain C region IGHA1 P01876 1,90 0,62 2,03 12,53 11,35 0,80 1,87 0,60 0,88 1,60 1,33 1,34 7 6 11 8 10 6 8 8 4 3 7 7 3 3 5 4 5 3 4 3 >sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1;>tr|F8W696|F8W696_HUMAN Truncated apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1Apolipoprotein A-I;Truncated apolipoprotein A-I APOA1 P02647 1,71 1,13 0,77 1,73 0,89 1,12 0,61 0,84 1,53 1,46 1,16 0,86 17 16 17 18 16 14 13 16 17 13 14 17 17 16 17 18 16 14 13 16 >sp|P01024|CO3_HUMAN Complement C3 OS=Homo sapiens GN=C3 PE=1 SV=2Complement C3;Complement C3 beta chain;Complement C3 alpha chain;C3a anaphylatoxin;Acylation stimulating protein;Complement C3b alpha chain;Complement C3c alpha chain fragment 1;Complement C3dg
    [Show full text]
  • Supplementary Table 1: Adhesion Genes Data Set
    Supplementary Table 1: Adhesion genes data set PROBE Entrez Gene ID Celera Gene ID Gene_Symbol Gene_Name 160832 1 hCG201364.3 A1BG alpha-1-B glycoprotein 223658 1 hCG201364.3 A1BG alpha-1-B glycoprotein 212988 102 hCG40040.3 ADAM10 ADAM metallopeptidase domain 10 133411 4185 hCG28232.2 ADAM11 ADAM metallopeptidase domain 11 110695 8038 hCG40937.4 ADAM12 ADAM metallopeptidase domain 12 (meltrin alpha) 195222 8038 hCG40937.4 ADAM12 ADAM metallopeptidase domain 12 (meltrin alpha) 165344 8751 hCG20021.3 ADAM15 ADAM metallopeptidase domain 15 (metargidin) 189065 6868 null ADAM17 ADAM metallopeptidase domain 17 (tumor necrosis factor, alpha, converting enzyme) 108119 8728 hCG15398.4 ADAM19 ADAM metallopeptidase domain 19 (meltrin beta) 117763 8748 hCG20675.3 ADAM20 ADAM metallopeptidase domain 20 126448 8747 hCG1785634.2 ADAM21 ADAM metallopeptidase domain 21 208981 8747 hCG1785634.2|hCG2042897 ADAM21 ADAM metallopeptidase domain 21 180903 53616 hCG17212.4 ADAM22 ADAM metallopeptidase domain 22 177272 8745 hCG1811623.1 ADAM23 ADAM metallopeptidase domain 23 102384 10863 hCG1818505.1 ADAM28 ADAM metallopeptidase domain 28 119968 11086 hCG1786734.2 ADAM29 ADAM metallopeptidase domain 29 205542 11085 hCG1997196.1 ADAM30 ADAM metallopeptidase domain 30 148417 80332 hCG39255.4 ADAM33 ADAM metallopeptidase domain 33 140492 8756 hCG1789002.2 ADAM7 ADAM metallopeptidase domain 7 122603 101 hCG1816947.1 ADAM8 ADAM metallopeptidase domain 8 183965 8754 hCG1996391 ADAM9 ADAM metallopeptidase domain 9 (meltrin gamma) 129974 27299 hCG15447.3 ADAMDEC1 ADAM-like,
    [Show full text]
  • Cellular and Molecular Signatures in the Disease Tissue of Early
    Cellular and Molecular Signatures in the Disease Tissue of Early Rheumatoid Arthritis Stratify Clinical Response to csDMARD-Therapy and Predict Radiographic Progression Frances Humby1,* Myles Lewis1,* Nandhini Ramamoorthi2, Jason Hackney3, Michael Barnes1, Michele Bombardieri1, Francesca Setiadi2, Stephen Kelly1, Fabiola Bene1, Maria di Cicco1, Sudeh Riahi1, Vidalba Rocher-Ros1, Nora Ng1, Ilias Lazorou1, Rebecca E. Hands1, Desiree van der Heijde4, Robert Landewé5, Annette van der Helm-van Mil4, Alberto Cauli6, Iain B. McInnes7, Christopher D. Buckley8, Ernest Choy9, Peter Taylor10, Michael J. Townsend2 & Costantino Pitzalis1 1Centre for Experimental Medicine and Rheumatology, William Harvey Research Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, Charterhouse Square, London EC1M 6BQ, UK. Departments of 2Biomarker Discovery OMNI, 3Bioinformatics and Computational Biology, Genentech Research and Early Development, South San Francisco, California 94080 USA 4Department of Rheumatology, Leiden University Medical Center, The Netherlands 5Department of Clinical Immunology & Rheumatology, Amsterdam Rheumatology & Immunology Center, Amsterdam, The Netherlands 6Rheumatology Unit, Department of Medical Sciences, Policlinico of the University of Cagliari, Cagliari, Italy 7Institute of Infection, Immunity and Inflammation, University of Glasgow, Glasgow G12 8TA, UK 8Rheumatology Research Group, Institute of Inflammation and Ageing (IIA), University of Birmingham, Birmingham B15 2WB, UK 9Institute of
    [Show full text]
  • Follicular Thyroglobulin Enhances Gene Expression Necessary for Thyroid Hormone Secretion
    Endocrine Journal 2015, 62 (11), 1007-1015 Original Follicular thyroglobulin enhances gene expression necessary for thyroid hormone secretion Yuko Ishido1), 2), 3), Yuqian Luo1), 3), Aya Yoshihara1), 3), Moyuru Hayashi3), Akio Yoshida2), Ichiro Hisatome2) and Koichi Suzuki1), 3) 1) Laboratory of Molecular Diagnostics, Department of Mycobacteriology, Leprosy Research Center, National Institute of Infectious Disease, Tokyo 189-0002, Japan 2) Division of Regenerative Medicine and Therapeutics, Department of Genetic Medicine and Regenerative Therapeutics, Institute of Regenerative Medicine and Biofunction, Tottori University Graduate School of Medical Science, Yonago, 683-8503, Japan 3) Department of Clinical Laboratory Science, Faculty of Medical Technology, Teikyo University, Tokyo 173-8605, Japan Abstract. We have previously shown that follicular thyroglobulin (Tg) has an unexpected function as an autocrine negative- feedback regulator of thyroid hormone (TH) biosynthesis. Tg significantly suppressed the expression of genes necessary for iodide transport and TH synthesis by counteracting stimulation by TSH. However, whether follicular Tg also regulates intracellular TH transport and its secretion from thyrocytes is not known. In the present study, we examined the potential effect of follicular Tg on TH transport and secretion by quantifying the expression of two TH transporters: monocarboxylate transporter 8 (MCT8) and μ-crystallin (CRYM). Our results showed that follicular Tg at physiologic concentrations enhanced both the mRNA and protein expression levels of MCT8 and CRYM in a time- and dose-dependent manner in rat thyroid FRTL-5 cells. Although both the sodium/iodide symporter (NIS), an essential transporter of iodide from blood into the thyroid, and MCT8, a transporter of synthesized TH from the gland, were co-localized on the basolateral membrane of rat thyrocytes in vivo, Tg decreased NIS expression and increased the expression of MCT8 by counteracting TSH action.
    [Show full text]
  • Natural Course of Congenital Hypothyroidism by Dual Oxidase 2 Mutations from the Neonatal Period Through Puberty
    Y Maruo and others Clinical features of DUOX2 174:4 453–463 Clinical Study defects Natural course of congenital hypothyroidism by dual oxidase 2 mutations from the neonatal period through puberty Yoshihiro Maruo1, Keisuke Nagasaki, Katsuyuki Matsui, Yu Mimura, Asami Mori, Maki Fukami2 and Yoshihiro Takeuchi Correspondence should be addressed Department of Pediatrics, Shiga University of Medical Science, Tsukinowa, Seta, Otsu, Shiga 520-2192, Japan, to Y Maruo 1Department of Pediatrics, Niigata University, Niigata, Japan and 2Department of Molecular Endocrinology, Email National Research Institute for Child Health and Development, Tokyo, Japan [email protected] Abstract Aim: We previously reported that biallelic mutations in dual oxidase 2 (DUOX2) cause transient hypothyroidism. Since then, many cases with DUOX2 mutations have been reported. However, the clinical features and prognosis of individuals with DUOX2 defects have not been clarified. Objective: We investigated the prognosis of patients with congenital hypothyroidism (CH) due to DUOX2 mutations. Patients: Twenty-five patients were identified by a neonatal screening program and included seven familial cases. Their serum TSH values ranged from 18.9 to 734.6 mU/l. Twenty-two of the patients had low serum free thyroxine (fT4) levels (0.17–1.1 ng/dl). Twenty-four of the patients were treated with L-thyroxine. Methods: We analyzed the DUOX2, thyroid peroxidase, NaC/IK symporter, and dual oxidase maturation factor 2 genes of these 25 patients by PCR-amplified direct sequencing. An additional 11 genes were analyzed in 11 of the 25 patients using next-generation sequencing. Results: All patients had biallelic DUOX2 mutations, and seven novel alleles were detected.
    [Show full text]
  • Structural and Biochemical Changes Underlying a Keratoderma-Like Phenotype in Mice Lacking Suprabasal AP1 Transcription Factor Function
    Citation: Cell Death and Disease (2015) 6, e1647; doi:10.1038/cddis.2015.21 OPEN & 2015 Macmillan Publishers Limited All rights reserved 2041-4889/15 www.nature.com/cddis Structural and biochemical changes underlying a keratoderma-like phenotype in mice lacking suprabasal AP1 transcription factor function EA Rorke*,1, G Adhikary2, CA Young2, RH Rice3, PM Elias4, D Crumrine4, J Meyer4, M Blumenberg5 and RL Eckert2,6,7,8 Epidermal keratinocyte differentiation on the body surface is a carefully choreographed process that leads to assembly of a barrier that is essential for life. Perturbation of keratinocyte differentiation leads to disease. Activator protein 1 (AP1) transcription factors are key controllers of this process. We have shown that inhibiting AP1 transcription factor activity in the suprabasal murine epidermis, by expression of dominant-negative c-jun (TAM67), produces a phenotype type that resembles human keratoderma. However, little is understood regarding the structural and molecular changes that drive this phenotype. In the present study we show that TAM67-positive epidermis displays altered cornified envelope, filaggrin-type keratohyalin granule, keratin filament, desmosome formation and lamellar body secretion leading to reduced barrier integrity. To understand the molecular changes underlying this process, we performed proteomic and RNA array analysis. Proteomic study of the corneocyte cross-linked proteome reveals a reduction in incorporation of cutaneous keratins, filaggrin, filaggrin2, late cornified envelope precursor proteins, hair keratins and hair keratin-associated proteins. This is coupled with increased incorporation of desmosome linker, small proline-rich, S100, transglutaminase and inflammation-associated proteins. Incorporation of most cutaneous keratins (Krt1, Krt5 and Krt10) is reduced, but incorporation of hyperproliferation-associated epidermal keratins (Krt6a, Krt6b and Krt16) is increased.
    [Show full text]
  • Comparative Mrna and Mirna Expression in European
    Heredity (2019) 122:172–186 https://doi.org/10.1038/s41437-018-0090-1 ARTICLE Comparative mRNA and miRNA expression in European mouflon (Ovis musimon) and sheep (Ovis aries) provides novel insights into the genetic mechanisms for female reproductive success 1 1,2 1,2 3 1,2 1,2 1,2 Ji Yang ● Xin Li ● Yin-Hong Cao ● Kisun Pokharel ● Xiao-Ju Hu ● Ze-Hui Chen ● Song-Song Xu ● 3 3 3 1 Jaana Peippo ● Mervi Honkatukia ● Juha Kantanen ● Meng-Hua Li Received: 12 January 2018 / Revised: 20 March 2018 / Accepted: 18 April 2018 / Published online: 21 May 2018 © The Author(s) 2018. This article is published with open access Abstract Prolific breeds of domestic sheep (Ovis aries) are important genetic resources due to their reproductive performance, which is characterized by multiple lambs per birth and out-of-season breeding. However, the lack of a comprehensive understanding of the genetic mechanisms underlying the important reproductive traits, particularly from the evolutionary genomics perspective, has impeded the efficient advancement of sheep breeding. Here, for the first time, by performing RNA-sequencing we built a de novo transcriptome assembly of ovarian and endometrial tissues in European mouflon (Ovis 1234567890();,: 1234567890();,: musimon) and performed an mRNA–miRNA integrated expression profiling analysis of the wild species and a highly prolific domestic sheep breed, the Finnsheep. We identified several novel genes with differentially expressed mRNAs (e.g., EREG, INHBA, SPP1, AMH, TDRD5, and ZP2) between the wild and domestic sheep, which are functionally involved in oocyte and follicle development and fertilization, and are significantly (adjusted P-value < 0.05) enriched in the Gene Ontology (GO) terms of various reproductive process, including the regulation of fertilization, oogenesis, ovarian follicle development, and sperm–egg recognition.
    [Show full text]
  • Table S1. the Clinicopathological Data of the Laryngeal Cancer Cases Involved in the Primary Tissue Culture
    Table S1. The clinicopathological data of the laryngeal cancer cases involved in the primary tissue culture Case Gender Age at Smoking Alcohol Histological type TNM Tumor coding* diagnosis status status staging† differentiation LC01 male 63 Yes Yes Supraglottic squamous cell carcinoma T4N2M0 Moderate LC14 male 73 Yes Yes Supraglottic squamous cell carcinoma T3N2M0 Moderate LC53 male 54 Yes No Supraglottic squamous cell carcinoma T3N2M0 Moderate LC95 male 50 Yes Yes Glottic squmamous cell carcinoma T3N1M0 Poor *LC represents laryngeal cancer. † staged according to Sixth Edition (2002) of the AJCC-UICC TNM Staging System. Table S2. The clinical characteristics of the 149 patients with laryngeal SCC used for ELISA Variable N (%) Variable N(%) Age (years) Disease stage ≤55 58 (38.9) I 33 (22.1) >55 91 (61.1) II 32 (21.5) Median (range) 58 (35-82) III 41 (27.5) IV 41 (27.5) Missing 2 (1.3) Gender T stage* Male 140 (94.0) T1 33 (21.5) Female 9 (6.0) T2 36 (24.2) T3 52 (34.9) T4 26 (17.4) Missing 2 (1.3) Smoking status Lymph node status Ever 124 (83.2) pN0 110 (73.8) Never 11 (7.4) pN+ 37 (24.8) Missing 14 (9.4) Missing 2 (1.3) Alcohol status Tumor differentiation Yes 84 (56.4) well 34 (22.8) No 51(34.2) moderate 78 (52.3) Missing 14 (9.4) poor 24 (16.1) Missing 13 (8.7) Anatomical region Glottis 82 (55.0) Supraglottis 60 (40.3) Subglottis 1 (0.7) Missing 6 (4.0) *staged according to Sixth Edition (2002) of the AJCC-UICC TNM Staging System.
    [Show full text]
  • ZP4 (C-Term) Rabbit Polyclonal Antibody – AP54737PU-N | Origene
    OriGene Technologies, Inc. 9620 Medical Center Drive, Ste 200 Rockville, MD 20850, US Phone: +1-888-267-4436 [email protected] EU: [email protected] CN: [email protected] Product datasheet for AP54737PU-N ZP4 (C-term) Rabbit Polyclonal Antibody Product data: Product Type: Primary Antibodies Applications: IHC, WB Recommended Dilution: ELISA: 1:1;000. Western blot: 1:100~500. Immunohistochemistry on paraffin sections: 1:10~50. Reactivity: Human Host: Rabbit Isotype: Ig Clonality: Polyclonal Immunogen: KLH conjugated synthetic peptide between 452-482 amino acids from the C-terminal region of human ZP4 Specificity: This antibody detects ZP4 / ZPB (C-term). Formulation: PBS with 0.09% (W/V) sodium azide State: Aff - Purified State: Liquid Ig fraction Concentration: lot specific Purification: Protein A column followed by peptide affinity purification Conjugation: Unconjugated Storage: Store at 2 - 8 °C for up to six months or (in aliquots) at -20 °C for longer. Avoid repeated freezing and thawing. Stability: Shelf life: one year from despatch. Gene Name: Homo sapiens zona pellucida glycoprotein 4 (ZP4) Database Link: Entrez Gene 57829 Human Q12836 This product is to be used for laboratory only. Not for diagnostic or therapeutic use. View online » ©2021 OriGene Technologies, Inc., 9620 Medical Center Drive, Ste 200, Rockville, MD 20850, US 1 / 2 ZP4 (C-term) Rabbit Polyclonal Antibody – AP54737PU-N Background: The zona pellucida is an extracellular matrix that surrounds the oocyte and early embryo. It is composed primarily of three or four glycoproteins with various functions during fertilization and preimplantation development. The nascent protein contains a N-terminal signal peptide sequence, a conserved ZP domain, a consensus furin cleavage site, and a C-terminal transmembrane domain.
    [Show full text]